Published in Healthcare Mergers, Acquisitions and Ventures Week, October 22nd, 2005
Within the scope of the agreement, Siemens has access to the know-how of the therapy planning system at the Paul Scherrer Institute (PSI). Both partners are joining forces to further develop proton therapy planning. Siemens will be provided with the opportunity of testing its own methods at PSI and will complement this offer by supporting research at the institute.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week